Gail Lieberman

CIK 1316742 · last filed 2025-08-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

20

Lifetime Open-Market Net

$25.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Midatech Pharma US Inc. (DARA) Delisted Director 0 $0 11 2015-12-07
DMX Director $50.17 $0 1 2007-08-15
BREEZE-EASTERN CORP (BZC) Delisted Director 9,282 $25.2K 1 2007-08-14

Recent Filings · Page 2 of 2

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-05-17 Midatech Pharma US Inc. (DARA) Delisted Grant (A) $0 EDGAR
2012-05-09 Grant (A) $0
2011-12-29 Midatech Pharma US Inc. (DARA) Delisted Grant (A) $0 EDGAR
2011-04-04 Midatech Pharma US Inc. (DARA) Delisted Grant (A) $0 EDGAR
2010-03-25 Midatech Pharma US Inc. (DARA) Delisted Grant (A) $0 EDGAR
2010-02-10 Midatech Pharma US Inc. (DARA) Delisted Grant (A) +3,333 $0 EDGAR
2009-05-08 Midatech Pharma US Inc. (DARA) Delisted Grant (A) $0 EDGAR
2008-05-02 Disp (D) $0
2007-08-15 DMX Grant (A) $0 EDGAR
2007-08-14 BREEZE-EASTERN CORP (BZC) Delisted Buy (P) +2,500 $25.2K EDGAR
Showing 1120 of 20
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.